Abstract
Cutaneous metastases from renal cell carcinoma (RCC) are uncommon, but may be painful and deforming. A review of the English language literature yields no references regarding the use of radiotherapy in the palliation of cutaneous RCC metastases. We report the first documented case of a patient with a single RCC facial metastatic nodule treated with hypofractionated electron beam radiotherapy followed by administration of sorafenib. The patient achieved a complete resolution of the cutaneous metastasis.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Benzenesulfonates / therapeutic use
-
Carcinoma, Renal Cell / drug therapy
-
Carcinoma, Renal Cell / radiotherapy*
-
Carcinoma, Renal Cell / secondary
-
Facial Neoplasms / drug therapy
-
Facial Neoplasms / radiotherapy*
-
Facial Neoplasms / secondary
-
Humans
-
Interleukin-2 / therapeutic use
-
Kidney Neoplasms / drug therapy
-
Kidney Neoplasms / pathology*
-
Male
-
Middle Aged
-
Niacinamide / analogs & derivatives
-
Palliative Care
-
Phenylurea Compounds
-
Pyridines / therapeutic use
-
Remission Induction
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / radiotherapy*
-
Skin Neoplasms / secondary
-
Sorafenib
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Interleukin-2
-
Phenylurea Compounds
-
Pyridines
-
Niacinamide
-
Sorafenib